PELLFICURE PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, October 28, 2014, a trademark application was filed for PELLFICURE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the PELLFICURE PHARMACEUTICALS trademark a serial number of 86437502. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 22, 2025. This trademark is owned by Pellficure Pharmaceuticals, Inc.. The PELLFICURE PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Medicaments for prostate cancer
pellficure pharmaceuticals

General Information

Serial Number86437502
Word MarkPELLFICURE PHARMACEUTICALS
Filing DateTuesday, October 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 22, 2025
Registration Number5675487
Registration DateTuesday, February 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements

Goods and ServicesMedicaments for prostate cancer
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 22, 2025
Primary Code005
First Use Anywhere DateMonday, August 7, 2017
First Use In Commerce DateMonday, August 7, 2017

Trademark Owner History

Party NamePELLFICURE PHARMACEUTICALS, INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLA JOLLA, CA 92037
Party NamePELLFICURE PHARMACEUTICALS, INC
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLA JOLLA, CA 92037
Party NamePellficure Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NamePellficure Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, October 31, 2014NEW APPLICATION ENTERED
Friday, November 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 20, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 17, 2015ASSIGNED TO EXAMINER
Friday, February 20, 2015EXAMINERS AMENDMENT E-MAILED
Friday, February 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 20, 2015EXAMINER'S AMENDMENT ENTERED
Monday, March 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 21, 2015ASSIGNED TO LIE
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 18, 2015SOU TEAS EXTENSION RECEIVED
Saturday, March 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 18, 2015SOU EXTENSION 1 FILED
Friday, December 18, 2015SOU EXTENSION 1 GRANTED
Tuesday, June 21, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, August 7, 2016SOU EXTENSION 2 GRANTED
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016SOU EXTENSION 3 FILED
Tuesday, December 20, 2016SOU EXTENSION 3 GRANTED
Tuesday, May 30, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017SOU EXTENSION 4 FILED
Tuesday, May 30, 2017SOU EXTENSION 4 GRANTED
Thursday, June 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2017TEAS STATEMENT OF USE RECEIVED
Friday, December 15, 2017SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2017SOU EXTENSION 5 FILED
Friday, December 15, 2017USE AMENDMENT FILED
Monday, December 18, 2017SOU EXTENSION 5 GRANTED
Tuesday, December 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2016SOU EXTENSION 2 FILED
Thursday, July 21, 2016DIVISIONAL REQUEST RECEIVED
Wednesday, July 20, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 12, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 22, 2025CANCELLED SEC. 8 (6-YR)
Monday, January 7, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2018STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

pharmaceuticals pellficure cancer prostate medicaments